| Company Name | Exchange | Ticker | Last Price | Day 1 (% Change) | Day 2 (% Change) | 52 WEEK HIGH | 52 WEEK LOW | Last Volume | M.Cap MM ($) |
| Conatus Pharmaceuticals Inc | NASDAQ | CNAT | 14.25 | 57.1% | 45.4% | 15.67 | 5.76 | 8,790,018 | 222.6 |
| Immunovaccine Inc | TSXV | IMV | 0.58 | 11.1% | 16.0% | 0.65 | 0.22 | 297,915 | 45.9 |
Today we feature two heathcare stocks as the top stocks of the previous trading session. These stocks recorded a strong price momentum during the past two trading session with significant volumes.
Conatus Pharmaceuticals Inc (NASDAQ: CNAT), a biotechnology company focused on the development and commercialization of medicines to treat liver disease, gained over 128% during its past two trading sessions gaining more than 45% in each of the two consecutive days. During its last trading session, the stock gained 45.4% and closed at $14.25 with significant trading volume of 8.8 million shares. During its past 5-trading sessions, CNAT gained 130.5% with 5-day average volume of 2.51 million shares compared to 1-month daily average volume of 511,421 shares.
Immunovaccine Inc (TSXV: IMV), a clinical stage vaccine development company focused on research and development of an early stage human health vaccine pipeline consisting of infectious diseases and therapeutic cancer vaccine products, gained over 29% during its past two trading sessions gaining more than 16% in each of the two consecutive days. During its last trading session, the stock gained 16% and closed at C$0.58 with significant trading volume of 297,915 shares. During its past 5-trading sessions, IMV gained 35% with 5-day average volume of 107,413 shares compared to 1-month daily average volume of 35,714 shares.
